
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
BAALC CRISPR/Cas9 KO Plasmid (h) | sc-405852 | 20 µg | $397.00 |
BAALC (brain and acute leukemia, cytoplasmic) encodes a cytoplasmic protein enriched in hematopoietic and neurodevelopmental contexts and implicated in regulation of progenitor cell state, including aspects of proliferation and differentiation. In myeloid lineages, BAALC expression is frequently used as a molecular correlate of immature transcriptional programs and altered signaling outputs, intersecting with pathways that shape cell-cycle progression, survival, and lineage commitment. Dysregulated BAALC levels have been associated with acute leukemias, where it is studied as part of broader gene expression networks linked to leukemogenesis and disease heterogeneity. These features make BAALC a useful node for dissecting mechanisms of stem/progenitor maintenance and aberrant hematopoietic signaling in human cellular models.
BAALC CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the BAALC gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the BAALC together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the BAALC open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish BAALC protein expression.
This CRISPR knockout system enables efficient generation of BAALC-deficient cell models for investigation of BAALC signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.